Longitudinal impact of asymptomatic malaria/HIV-1 co-infection on Plasmodium falciparum gametocyte transcript expression and transmission to Anopheles mosquitoes

• Published in: Frontiers in cellular and infection microbiology 2022-09, Vol.12, p.934641
• Main Authors: Roberds, Ashleigh, Kifude, Carolyne, Oyieko, Janet, Ocholla, Stephen, Mutunga, James, Oullo, David, Waga, Charles, Li, Zhaozhang, Luckhart, Shirley, Stewart, V Ann
• Format: Article
• Language: English
• Subjects: Animals; Anopheles - parasitology; Antimalarials - therapeutic use; Artemether; Artemether, Lumefantrine Drug Combination - therapeutic use; Cellular and Infection Microbiology; co-infection; Coinfection; ddPCR; gametocytes; HIV; HIV Infections - complications; HIV-1 - genetics; Humans; Malaria; Malaria, Falciparum - epidemiology; Malaria, Falciparum - parasitology; Parasitemia - parasitology; plasmodium falciparum; Plasmodium falciparum - genetics; RNA, Ribosomal, 18S; Trimethoprim, Sulfamethoxazole Drug Combination
• ISSN: 2235-2988; 2235-2988
• DOI: 10.3389/fcimb.2022.934641

Despite significant developments towards malaria reduction, parasite transmission in the common context of HIV-1 co-infection and treatment for one or both infections has not been fully characterized. This is particularly important given that HIV-1 and malaria chemotherapies have the potential to alter gametocyte burden and mosquito infectivity. In this study, we examined 782 blood samples collected from a longitudinal cohort of 300 volunteers with asymptomatic parasitemia seeking HIV testing or treatment in the endemic region of Kisumu, Kenya, to define the impacts of HIV-1-malaria co-infection, antiretroviral therapy (ART) plus trimethoprim-sulfamethoxazole (TS) and the antimalarials artemether/lumefantrine (AL) on gametocyte transcript prevalence and parasite transmission to the African malaria mosquito . Volunteers were assigned to three distinct HIV-1 groups: HIV-1 positive on treatment, HIV-1 positive newly diagnosed, and HIV-1 negative. Volunteers were monitored monthly over the course of six months. Using our highly sensitive digital droplet PCR (ddPCR) assay of three gametocyte specific transcript markers, we detected gametocyte transcripts in 51.1% of positive volunteers across all study groups and time points. After correcting for multiple comparisons, the factors of HIV-1 status, time, CD4+ T-cell levels and hematocrit were not predictive of gametocyte prevalence or transmission. However, among those volunteers who were newly diagnosed with HIV-1 and malaria positive by rapid diagnostic test (RDT) at enrollment, the initiation of ART/TS and AL treatment was associated with a significant reduction in gametocyte transcript prevalence in the subsequent month when compared to HIV-1 negative volunteers treated with AL. To assess gametocyte transmissibility, volunteer blood samples were used in standard membrane feeding assays (SFMA) with laboratory-reared , with evidence of transmission confirmed by at least one of 25 dissected mosquitoes per sample positive for at least one midgut oocyst. HIV-1 status, CD4+ T-cell levels and hematocrit were not significantly associated with successful transmission to Analysis of SMFA blood samples revealed that 50% of transmission-positive blood samples failed to test positive by -specific ribosomal RNA quantitative PCR (qPCR) and 35% failed to test positive for any gametocyte specific transcript marker by droplet digital (ddPCR), documenting that transmission occurred in the absence of molecular parasite/gametocyt